Indo US Bio-Tech Ltd

NSE:INDOUSBasic Materials

₹63.80−6.08%At closeAt close · Fri 23 Oct · ≈ AED 2.47 · Market cap $13.49M

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.4	0.5	0.6	0.7	1.0	1.1	1.1	+2.0%
Cost of revenue	0.3	0.4	0.5	0.5	0.7	0.8	0.9	+4.8%
Gross profit	0.1	0.1	0.2	0.2	0.3	0.3	0.3	−6.3%
Research & development	0.0	0.0	0.0	0.1	0.0	0.0	—	—
Selling, general & administrative	0.0	0.0	0.0	0.0	0.0	0.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.1	0.1	0.0	0.1	0.1	0.1	0.1	−1.6%
Operating income	0.1	0.1	0.1	0.1	0.2	0.2	0.1	−9.8%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	+12.9%
Interest income	0.0	0.0	(0.0)	0.0	0.0	0.0	0.0	—
Other income / expense	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	—	—
Pre-tax income	0.0	0.1	0.1	0.1	0.2	0.1	0.1	−12.5%
Income tax	(0.0)	0.0	0.0	0.0	0.0	0.0	0.0	−9.8%
Net income	0.0	0.1	0.1	0.1	0.2	0.1	0.1	−12.7%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	3.36	4.14	3.75	4.11	8.12	6.54	5.71	−12.6%
EPS, diluted (per share)	3.36	4.14	3.75	4.11	8.12	6.54	5.71	−12.6%
EBITDA	0.1	0.1	0.1	0.1	0.2	0.2	0.2	−8.9%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Weighted average shares (shares)	14,563,176	12,239,274	19,289,224	20,052,000	20,034,000	20,066,000	—	—
Weighted average diluted shares (shares)	14,563,176	12,239,274	19,289,224	20,052,000	20,034,000	20,066,000	—	—
Gross margin	32.3%	26.4%	25.3%	28.4%	27.9%	25.2%	23.2%	−2.1 pts
Operating margin	12.8%	13.3%	13.9%	15.5%	17.2%	14.6%	12.9%	−1.7 pts
Net margin	12.2%	10.5%	11.7%	11.3%	15.7%	11.9%	10.2%	−1.7 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.